Extended Treatment Duration for Hepatitis C Virus Type 1: Comparing 48 Versus 72 Weeks of Peginterferon-Alfa-2a Plus Ribavirin

Authors:

Abstract
No abstract available
Funding Information
  • Bundesministerium für Forschung, Technologie und Raumfahrt (01 KI 0102)
  • F. Hoffmann-La Roche

This publication has 20 references indexed in Scilit: